focused on biologics for the prevention and treatment of serious infectious diseases
home
about us
product pipeline
scientific publications
investors
press releases
events
sec filings
interactive stock chart
historical stock price
annual meeting materials
analyst coverage
corporate governance
investor alerts
fundamentals
contact us
careers
investors
recent press releases
May 15, 2013
Synthetic Biologics Reports First Quarter 2013 Financial Results
Apr 19, 2013
Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
Apr 16, 2013
Synthetic Biologics Reports Year End 2012 Financial Results
events
Marcum Microcap Conference
Thursday, May 30, 2013
10:00am EDT
25th Annual ROTH Conference
Tuesday, March 19, 2013
1:30pm PDT
2013 BIO CEO & Investor Conference
Tuesday, February 12, 2013
11:00am EST
Price Data
NYSE MKT
SYN
1dy
1mo
6mo
1yr
5yr
Print
Email
forward-looking statements
© Synthetic Biologics, Inc. 2013